Treatment of shock using adrenomedullin and adrenomedullin binding protein-1

   
   

The present invention provides methods of preventing organ destruction and shut-down due to shock in a patient suffering from sepsis or at risk for sepsis, comprising administering adrenomedullin and adrenomedullin binding protein-1 to the patient. Also provided are compositions containing adrenomedullin and adrenomedullin binding protein-1 or precursors, in a pharmaceutically acceptable carrier.

La présente invention fournit des méthodes d'empêcher la destruction et l'arrêt d'organe dus au choc dans un patient souffrant du sepsis ou en danger pour le sepsis, comportant administrant l'adrenomedullin et l'adrenomedullin liant protein-1 du patient. En outre fournies sont des compositions contenant l'adrenomedullin et l'adrenomedullin liant protein-1 ou précurseurs, dans un porteur pharmaceutiquement acceptable.

 
Web www.patentalert.com

< Biglycan and related therapeutics and methods of use

< Isolated nucleic acids encoding methylenetetrahydrofolate dehydrogenase enzymes

> Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor

> Method for producing .alpha.-hydroxycarboxylic acid

~ 00166